MAPT and Lewy body dementia: For the α-Syn and tau seed experiments, we used brain homogenates from patients with neuropathologically confirmed diagnoses of dementia with Lewy Bodies (DLB) or sporadic Alzheimer’s disease (sAD), respectively.